Zopya 75 mg film-coated tablets

Illustration Zopya 75 mg film-coated tablets
Substance(s) Picotamide
Admission country United Kingdom
Manufacturer Norpharm Regulatory Services Ltd.
Narcotic No
ATC Code B01AC03
Pharmacological group Antithrombotic agents

Authorisation holder

Norpharm Regulatory Services Ltd.

Drugs with same active substance

Drug Substance(s) Authorisation holder
Zylagren 75 mg film-coated tablets Picotamide Krka, D.D., Novo Mesto

Patient’s Leaflet

What is it and how is it used?

Zopya belongs to a group of medicines called antiplatelet medicinal products. Platelets are very small structures in the blood, which clump together during blood clotting. By preventing this clumping, antiplatelet medicinal products reduce the chances of blood clots forming (a process called thrombosis).

Zopya is taken to prevent blood clots (thrombi) forming in hardened blood vessels (arteries), a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).

You have been prescribed Zopya to help prevent blood clots and reduce the risk of these severe events because:

  • You have a condition of hardening of arteries (also known as atherosclerosis), and
  • You have previously experienced a heart attack, stroke or have a condition known as peripheral arterial disease.

Ad

What do you have to consider before using it?

Do not take Zopya
  • if you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of Zopya;
  • if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain;
  • if you suffer from severe liver disease; If you think any of these apply to you, or if you are in any doubt at all, consult your doctor before taking Zopya.

Take special care with Zopya

If any of the situations mentioned below apply to you, you should tell your doctor before taking Zopya:

  • if you have a risk of bleeding such as
  • a medical condition that puts you at risk of internal bleeding (such as a stomach ulcer)
  • a blood disorder that makes you prone to internal bleeding (bleeding inside any tissues, organs or joints of your body).
  • a recent serious injury
  • a recent surgery (including dental)
  • a planned surgery (including dental) in the next seven days
  • if you have had a clot in an artery of your brain (ischaemic stroke) which occurred within the last seven days
  • if you have kidney or liver disease.

While you are taking Zopya:

  • You should tell your doctor if a surgery (including dental) is planned.
  • You should also tell your doctor immediately if you develop a medical condition that includes fever and bruising under the skin that may appear as red pinpoint dots, with or without unexplained extreme tiredness, confusion, yellowing of the skin or eyes (jaundice) (see ?Possible side effects?).
  • If you cut or injure yourself, it may take longer than usual for bleeding to stop. This is linked to the way your medicine works as it prevents the ability of blood clots to form. For minor cuts and injuries e.g., cutting yourself, shaving, this is usually of no concern. However, if you are concerned by your bleeding, you should contact your doctor straightaway (see ?Possible side effects?).
  • Your doctor may order blood tests.
  • You should tell your doctor or pharmacist if you notice any side effect not listed in the see ?Possible side effects? section of this leaflet or if you notice that a side effect gets serious.

Zopya is not intended for use in children or adolescents.

Taking other medicines

Some other medicines may influence the use of Zopya or vice versa.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

The use of oral anticoagulants (a medicine used to reduce blood clotting) with Zopya is not recommended.

You should specifically tell your doctor if you take a non-steroidal anti-inflammatory medicinal product, usually used to treat painful and/or inflammatory conditions of muscle or joints, or if you take heparin, or any other medicine used to reduce blood clotting.

An occasional use of acetylsalicylic acid (no more than 1000 mg in any 24 hour period), a substance present in many medicines used to relieve pain and lower fever, should generally not cause a problem, but prolonged use in other circumstances should be discussed with your doctor.

Taking Zopya with food and drink
Food/meals have no influence. Zopya may be taken with or without food.

Pregnancy and breast-feeding

It is preferable not to use this product during pregnancy and breast-feeding.

If you are pregnant or suspect that you are pregnant, you should tell your doctor or your pharmacist before taking Zopya. If you become pregnant while taking Zopya, consult your doctor immediately as it is recommended not to take clopidogrel while you are pregnant.

While taking Zopya, consult your doctor about the breast-feeding of a baby.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines
Zopya is unlikely to affect your ability to drive or to use machines.

Important information about some of the ingredients of Zopya

Zopya contains hydrogenated castor oil which may cause stomach upset and diarrhoea.

Ad

How is it used?

Always take Zopya exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The usual dose is one 75 mg tablet of Zopya per day to be taken orally with or without food, and at the same time each day.

You should take Zopya for as long as your doctor continues to prescribe it.

If you take more Zopya than you should:
Contact your doctor or the nearest emergency department because of the increased risk of bleeding.

If you forget to take Zopya:
If you forget to take a dose of Zopya, but remember within 12 hours of your usual time, take your tablet straightaway and then take your next tablet at the usual time.
If you forget for more than 12 hours, simply take the next single dose at the usual time. Do not take a double dose to make up for a forgotten tablet dose.

If you stop taking Zopya:

Do not stop the treatment. Contact your doctor or pharmacist before stopping.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Ad

What are possible side effects?

Like all medicines, Zopya can cause side effects, although not everybody gets them.

Contact your doctor immediately if you experience:

  • fever, signs of infection or extreme tiredness. These may be due to rare decrease of some blood cells.
  • signs of liver problems such as yellowing of the skin and/or the eyes (jaundice), whether or not associated with bleeding which appears under the skin as red pinpoint dots and/or confusion (see ?Take special care with Zopya?).
  • swelling in the mouth or skin disorders such as rashes and itching, blisters of the skin. These may be the signs of an allergic reaction.

The most common side effect (affects 1 to 10 patients in 100) is bleeding.
Bleeding may occur as bleeding in the stomach or bowels, bruising, haematoma (unusual bleeding or bruising under the skin), nose bleed, blood in the urine. In a small number of cases, bleeding in the eye, inside the head, the lung or the joints has also been reported.

If you experience prolonged bleeding when taking Zopya

If you cut or injure yourself, it may take slightly longer than usual for bleeding to stop. This is linked to the way your medicine works as it prevents the ability of blood clots to form. For minor cuts and injuries e.g., cutting yourself, shaving, this is of no concern. However, if you are concerned by your bleeding, you should contact your doctor straightaway (see ?Take special care with Zopya?).

Other side effects reported are

Common side effects (affects 1 to 10 patients in 100): Diarrhoea, abdominal pain, indigestion or heartburn.

Uncommon side effects (affects 1 to 10 patients in 1,000): Headache, stomach ulcer, vomiting, nausea, constipation, excessive gas in stomach or intestines, rashes, itching, dizziness, abnormal touch sensation.

Rare side effect (affects 1 to 10 patients in 10,000): Vertigo.

Very rare side effects (affects less than 1 patient in 10,000): jaundice; severe abdominal pain with or without back pain; fever, breathing difficulties sometimes associated with cough; generalised allergic reactions; swelling in the mouth; blisters of the skin; skin allergy; inflammation of the mouth (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscular pain; taste disorders.

In addition, your doctor may identify changes in your blood or urine test results.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Ad

How should it be stored?

Keep out of the reach and sight of children.
Do not use Zopya after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

Store in the original package in order to protect from moisture and light.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Ad

Further information

What Zopya contains

The active substance is clopidogrel. Each film-coated tabletcontains 75 mg of clopidogrel (as hydrochloride).

The other ingredients are microcrystalline cellulose, colloidal anhydrous silica, crospovidone (type A), macrogol 6000, hydrogenated castor oil in the tablet core and hydroxypropylcellulose (E463), titanium dioxide (E171), red iron oxide (E172), talc and propylene glycol in the film-coating.

What Zopya looks like and contents of the pack

The film-coated tablets are pink, round and slightly convex.
Boxes of 7, 14, 28, 30, 50, 56, 84, 90 and 100 film-coated tablets in blisters are available.

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Norpharm Regulatory Services Ltd, 26 Laurence Street, Drogheda, Co. Louth, Ireland

Manufacturer:
KRKA, d.d., Novo mesto, ?marje?ka cesta 6, 8501 Novo mesto, Slovenia

TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany

This leaflet was last approved in MM/YYYY.

Ad

Substance(s) Picotamide
Admission country United Kingdom
Manufacturer Norpharm Regulatory Services Ltd.
Narcotic No
ATC Code B01AC03
Pharmacological group Antithrombotic agents

Share

Ad

Your personal medicine assistent

afgis-Qualitätslogo mit Ablauf Jahr/Monat: Mit einem Klick auf das Logo öffnet sich ein neues Bildschirmfenster mit Informationen über medikamio GmbH & Co KG und sein/ihr Internet-Angebot: medikamio.com/ This website is certified by Health On the Net Foundation. Click to verify.
Drugs

Search our database for drugs, sorted from A-Z with their effects and ingredients.

Substances

All substances with their common uses, chemical components and medical products which contain them.

Diseases

Causes, symptoms and treatment for the most common diseases and injuries.

The contents shown do not replace the original package insert of the medicinal product, especially with regard to dosage and effect of the individual products. We cannot assume any liability for the correctness of the data, as the data was partly converted automatically. A doctor should always be consulted for diagnoses and other health questions. Further information on this topic can be found here.